Study suggests Siemens non-invasive blood test may have a role in monitoring breast c
 

Siemens Healthcare announced that data from a new study published in the American Cancer Society journal Cancer, supports using the Siemens Serum HER-2/neu test to monitor patients with an aggressive type of metastatic breast cancer.

More...